Effect of exogenous and endogenous antioxidants on 3-nitropropionic acid-induced in vivo oxidative stress and striatal lesions: Insights into Huntington's disease

Journal of Neurochemistry

Volumn 75, Issue 4, 2000, Pages 1709-1715

  La Fontaine, Michael A ^a,b   Geddes, James W ^a,b   Banks, Andrea ^a,b   Allan Butterfield, D ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

3 Nitropropionic acid; 5 Diethoxyphosphoryl 5 methyl 1 pyrroline N oxide; Electron paramagnetic resonance; Glutathione; Huntington's disease; N Acety lcysteine; Oxidative stress

Indexed keywords

3 NITROPROPIONIC ACID; 5 DIETHOXYPHOSPHORYL 5 METHYL 1 PYRROLINE 1 OXIDE; ACETYLCYSTEINE; ANTIOXIDANT; CARBONYL DERIVATIVE; GLUTATHIONE; MEMBRANE PROTEIN; SUCCINATE DEHYDROGENASE (UBIQUINONE); UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; BRAIN SYNAPTOSOME; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; HUNTINGTON CHOREA; IN VIVO STUDY; MALE; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN METABOLISM; RAT; TREATMENT OUTCOME;

ACETYLCYSTEINE; ANIMALS; ANTIOXIDANTS; CEREBRAL CORTEX; CORPUS STRIATUM; CYCLIC N-OXIDES; ELECTRON SPIN RESONANCE SPECTROSCOPY; GLUTATHIONE; HUNTINGTON DISEASE; MALE; MEMBRANE PROTEINS; NITRO COMPOUNDS; OXIDATIVE STRESS; PROPIONIC ACIDS; RATS; RATS, SPRAGUE-DAWLEY; SYNAPTIC MEMBRANES; SYNAPTOSOMES;

ANIMALIA;

EID: 0033812145     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2000.0751709.x     Document Type: Article

References (52)

1. Oxidative modification of glutamine synthetase by amyloid beta peptide
2. Alternative excitotoxic hypothesis
3. Striatal and nigral neuron subpopulation in rigid Huntington's disease: Implication for the functional anatomy of chorea and rigidity-akinesia
4. Mechanisms of excitotoxicity in neurological diseases
5. Chronic quinolinic acid lesions in rats closely resemble Huntington's disease
6. Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate
7. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid
8. 3-Nitropropionic acid neurotoxicity is attenuated in copper/zinc superoxide dismutase transgenic mice
9. Hyperactivity and hypoactivity in a rat model of Huntington's disease: The systemic 3-nitropropionic acid model
10. Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid
11. Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH
12. β-Amyloid-associated free radical oxidative stress: Implications for Alzheimer's disease
13. Protein oxidation processes in aging brain
14. β-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: Implications to Alzheimer's disease
15. Free radical oxidation of brain proteins in accelerated senescence and its modulation by N-tert-butyl-α-phenylnitrone
16. Use of a phosphorylated spin trap to discriminate between the hydroxyl radical and other oxidizing species
17. Oxidative stress, glutamate and neurodegenerative disorders
18. Age-related losses of cognitive function and motor skills in mice are associated with oxidative protein damage in the brain
19. Antibody probing on western blots that have been stained with India ink
20. Quantifiable bradykinesia, gait abnormalities, and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid
21. Ischemia/reperfusion induced changes in membrane proteins and lipids of gerbil cortical synaptosomes
22. Prevention of ischemia/reperfusion induced alterations in synaptosomal membrane-associated proteins and lipids by N-tert-butyl-α-phenylnitrone and difluoromethylornithine
23. Structural alterations in synaptosomal membrane-associated proteins and lipids by transient middle cerebral artery occlusion in the cat
24. Electron paramagnetic resonance investigations of free-radical induced alterations in neocortical synaptosomal membrane protein infrastructure
25. Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation
26. Prevention of hyperoxia-induced alterations in synaptosomal membrane-associated proteins by N-tert-butyl-α-phenylnitrone and 4-hydroxy-2,2,6,6-tetramethylpiperidin-1-oxyl (TEMPO)
27. A novel gene containing a trinucleotide repeat that is expanded and unstable in Huntington's disease chromosome
28. Intrastriatal 3-nitropropionic acid: A behavioral assessment
29. New insights into the clinical features, pathogenesis and molecular genetics of Huntington's disease
30. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
31. 3-Nitropropionic acid-induced in vivo protein oxidation in striatal and cortical synaptosomes: Insights into Huntington's disease
32. NMDA-dependent superoxide production and neurotoxicity
33. Protein measurement with the Folin phenol reagent
34. 3-Nitropropionic acid decreases cellular energy levels and causes neuronal degeneration in cortical explants
35. Effects of α-phenyl-tert-butyl nitrone on neuronal survival and motor function following intrastriatal injections of quinolinate or 3-nitropropionic acid
36. 3-Nitropropionic acid produces striatum selectire lesions accompanied by iNOS expression
37. Chronic 3-nitropropionic acid treatment in baboons replicates the cognitive and motor deficits of Huntington's disease
38. Mechanisms of cell death induced by the mitochondrial toxin 3-nitropropionic acid: Acute excitotoxic necrosis and delayed apoptosis
39. In-vivo glutathione elevation protects against hydroxyl free radical-induced protein oxidation in rat brain
40. Glutamate induces the production of reactive oxygen species in cultured forebrain neurons following NMDA receptor activation
41. Involvement of free radicals in excitotoxicity in vivo
42. Involvement of oxidative stress in 3-nitropropionic acid neurotoxicity
43. The lipid peroxidation product, 4-hydroxy-2-trans-nonenal, alters the conformation of cortical synaptosomal membrane proteins
44. The free radical antioxidant vitamin E protects cortical synaptosomal membrane proteins from amyloid β-peptide (25-35) toxicity but not from hydroxynonenal toxicity: Relevance to the free radical hypothesis of Alzheimer's disease
45. Biochemical abnormalities and excitotoxicity in Huntington's disease brain
46. Mitochondrial dysfunction and free radical damage in the Huntington r6/2 transgenic mouse
47. Effects of reduced glutathione and N-acetyl cysteine on lidocaine metabolism in cimetidine treated rats
48. Membrane induced cytotoxicity effects on human erythrocyte membranes studied by electron paramagnetic resonance
49. 1H nuclear magnetic resonance spectroscopy and biochemical characterization
50. Spin-labeling of membrane proteins in mammalian brain synaptic plasma membranes; partial characterization
51. 3-Nitropropionic acid toxicity in the striatum